Hema Now | Episode 17
In this episode of Hema Now, host Jonathan Sackier is joined by Rafael Fonseca, Consultant at the Division of Hematology/Oncology at the Mayo Clinic. Together, they delve into the biology, diagnosis, and evolving management of multiple myeloma and related plasma cell disorders. Their conversation addresses common misunderstandings about myeloma, differentiates between its various forms and stages, and highlights Fonseca’s pioneering research.
Apple | Amazon Music | YouTube | Download MP3 (29 mins)
Rafael Fonseca
Rafael Fonseca is a distinguished Haematologist at Mayo Clinic, specialising in multiple myeloma and related plasma cell disorders. He earned his medical degree at Universidad Anáhuac in Mexico, and went on to complete his residency in Internal Medicine at the University of Miami, Florida, USA followed by a Hematology and Oncology fellowship at Mayo Clinic in Rochester, Minnesota.
Timestamps:
01:44 – Quickfire questions
07:25 – CAR-T cell therapy
10:48 – Anti-CD38 antibodies
13:31 – Minimal residual disease
14:30 – Bispecific antibodies
15:31 – Antibody-drug conjugates
19:04 – ASCO 2025
21:24 – Genetic discoveries
26:28 – Fonseca’s three wishes
The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
